Delayed-type hypersensitivity reaction to anthrax vaccine

Abstract

The Anthrax Vaccine Immunization Program is a Department of Defense initiative to protect military personnel against the threat of anthrax. Surveillance for adverse events associated with anthrax vaccination has shown that mild local reactions are not uncommon while systemic reactions are extremely rare. We present a case of a 26-year-old male with delayed-type hypersensitivity after two doses of anthrax vaccine.